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ABSTRACT
Purpose: Different biomaterials have been suggested for guided bone regeneration (GBR). These might show the ideal
properties to let a new bone formation in the grafted area. Among these ideal features, it is essential their controlled
resorption in order to be replaced for new vital bone. Bovine bone has been used widely as a good biomaterial for GBR,
however there is still an interesting controversy about its resorbable capacity. In this sense, the objective of this study was
to examine the behavior of anorganic bovine bone (ABB) in long-term maxillary sinus graft healing and study its
relationship with morphological and morphometrical variables.
Materials and Methods: Seventeen maxillary sinus augmentation procedures were performed in patients. Bone cores were
obtained from implant receptor sites at 6 months, 3 years, and 7 years of implant placement for histological, morphometric,
and immunohistochemical (tartrate resistant acid phosphatase [TRAP]/cathepsin K/CD68) studies.
Results: The percentages of bone, ABB particles, connective tissue, osteocytes, and osteoblasts in maxillary sinus grafts were
similar at 6 months, 3 years, and 7 years. A progressive and significant decrease was detected in osteoclasts (p = .05,
Kruskal-Wallis test), TRAP and cathepsin K expression (p = .014 and p = .021, respectively), and osteoid lines (p = .038).
Conclusion: According to these data, a decrease in osteoclasts over time may, partially, explain the ABB persistence observed
in core biopsies. Further studies with more cases and different graft maturation times are required to elucidate the
resorption rates and cell events underlying these phenomena.
KEY WORDS: anorganic bovine bone, bone remodeling, cathepsin K, immunohistochemistry, intrasinus graft, osteo-
clasts, osteocyte, resorption, TRAP
INTRODUCTION
Multiple types of bone graft material (autogenic, allo-
genic, xenogeneic, and alloplastic) have been used for
bone defect repair and sinus augmentation to provide
structural and mechanical support for the placement of
dental implants.1 Successful graft consolidation relies
on the progressive apposition of newly formed vital
bone, followed by functional remodeling and progres-
sive replacement of the grafting material by vital tissue.2
Therefore, according to the ideal criteria for a biomate-
rial, bone substitute biomaterials should be osteogenic,
osteoconductive, and/or osteoinductive,3 promote
angiogenesis,4 and be replaced in the same quality and
quantity by new vital bone. Ideally, bone substitute bio-
material is eliminated slowly after implantation in the
patient,5 but its biodegradation rate allows the mechani-
cal strength of the graft to be maintained during heal-
ing,6 balancing the resorption rate of the biomaterial
with the patient’s ability to form new bone.7
Over the past two decades, clinical and scientific
research has demonstrated that the utilization of anor-
ganic bovine bone (ABB) as grafting material can
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produce very high clinical success rates.8 ABB is a depro-
teinized, sterilized, bovine cancellous bone that provides
a scaffold and a matrix for bone cell migration and
is integrated into the natural physiologic remodeling
process; it is frequently utilized as a bone substitute
when insufficient autogenous cortical bone (ACB) is
available for the graft.9
Knowledge of the resorption of available biomate-
rials is important for the clinician in order to obtain a
satisfactory clinical outcome.10 The resorption of ABB
remains controversial, and results have varied according
to the model used (human11,12 or animal13,14), the cell
type investigated (e.g., giant cells15 or osteoclasts10,16),
the pathological technique,17 or the histological prepa-
ration method.18
Osteoclasts develop on bone surfaces, whereas other
multinucleated cells, such as giant cells, primarily differ-
entiate at chronic inflammatory sites in response to
bacterial invasion or foreign bodies.19 A foreign body
reaction can be caused by a xenograft that is clinically
nonimmunogenic, nontoxic, and chemically inert,15
which can impair hard tissue deposition20 and modify its
osteoconductive properties. A better understanding of
the osteoclastic degradation of bone substitute materials
is of interest because osteoclastic resorption may affect
bone formation during the coupled activity of bone
cells in the remodeling process.21 It is documented
that multinucleated cells originate from mononuclear
phagocytes that belong to the hematopoietic line of stem
cells.22 The biological processes that differentiate the
final cellular type from monocytes or macrophages may
be conditioned by local stimuli such as growth factors or
cytokines. Hence, different responses may be expected
according to the biological milieu of the biomaterial site.
The objective of this study was to examine the
behavior of ABB in maxillary sinus grafts at 6 months, 3
years, and 7 years after healing, analyzing the types of
degrading cells related to ABB particles, determining
ABB resorption in core biopsies from humans after sinus
augmentation with a composite graft composed of ABB
and ACB (1:1 ratio), and studying its relationship with
morphological and morphometric variables.
MATERIALS AND METHODS
Study Design
Patients in need of sinus augmentation were recruited
for this prospective study at the University of Granada
(Spain), which was conducted in accordance with the
Helsinki declaration23 and approved by the ethical com-
mittee of the university for studies involving human
subjects. Informed consent to study participation was
obtained from patients during the screening phase.
Information on their medical and dental history was
gathered by means of a questionnaire. Inclusion criteria
were the following: age between 18 and 85 years, physical
status of I or II according to the American Society
of Anesthesiologists, absence of uncontrolled systemic
disease or condition known to alter bone metabolism
(e.g., osteoporosis, diabetes mellitus, etc.), adequate
oral hygiene (O’Leary plaque score 220%), and <5-mm
remaining bone height by radiographic measurement
on panoramic film.24 Exclusion criteria were the follow-
ing: receipt of antibiotics in previous 3 months, long-
term use (>6 months) of medications known to modify
bone metabolism (e.g., bisphosphonates, corticoster-
oids, etc.), pregnancy or intention to become pregnant,
the presence of sinus conditions or sepsis, and a history
of cancer and/or irradiation in the oral cavity.
Seventeen grafting procedures were conducted
using a previously reported surgical and restorative
procedure.25 Patients underwent a delayed implant
approach of between 6 months, although some of them
required implant placement after periods of 3 years and
even 7 years. A trephine (3 mm internal diameter, 4 mm
external diameter) was used to collect bone core biopsies
after a 6-month healing period in 10 cases, after a delay
of 3 years in four cases, and after a delay of 7 years in
three cases. The number of patients in this study is
limited because of the singularity to take bone cores
from patients after 3 or 7 years after grafting, due to
ethical reasons. Especial circumstances are needed to
involve these patients in this study, such as failed
implants in the surrounding area, patients that moved to
a different area to live and left their treatments without
placing the fixations, or illness (different from the exclu-
sion criteria) that did not allow the patients to attend to
their normal appointments.
Radiographic Variables
Standardized digital panoramic films (Kodak ACR-
2000, Eastman Kodak Company, Rochester, NY, USA)
were obtained for each patient before and immediately
after the sinus graft surgery, before the implant inser-
tion, and at prosthesis delivery. A single examiner used
specific software (Digident Dent-A-View, Version 1.0,
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DigiDent, DIT, Nesher, Israel) to measure the total bone
height at the point of shortest remaining alveolar bone
before the surgery and the maximum vertical augmen-
tation after grafting and at implant placement.
Histological Study. Harvested biopsies were immediately
placed in 10% buffered formalin for 24 hours, then
decalcified in a solution containing formaldehyde (10%
w/v), formic acid (8% w/v), and methanol (1% w/v) for
320 days (Decalcifier I, Surgipath® Europe Ltd, Peter-
borough, UK), and subsequently embedded in paraffin.
Samples were dewaxed and hydrated, and 4-mm sections
were cut along the central axis of the biopsies. Sections
were processed for hematoxylin-eosin, periodic acid
Schiff, and Masson’s trichrome staining. A millimeter
scale in the eyepiece of a BH2 microscope (Olympus
Optical Company, Ltd, Tokyo, Japan) was used (at ¥40
magnification) to count osteoblasts, osteoclasts, and
osteocytes per square millimeter. Results were expressed
as number of positive cells per square millimeter. Bone
histomorphometric analysis was semiautomatically per-
formed on Masson trichrome-stained sections by assess-
ing 10 random digital images per sample, obtained with
a microscope (¥10 magnification) equipped with digital
camera (DP70, Olympus). Images were transferred to
a computer and analyzed using specialized software
(Image J, NIH, Scion Corporation, Frederick, MD, USA,
http://rsb.info.nih.gov/ij/). Vital bone, remaining ABB
particles, and nonmineralized tissue percentages were
separately quantified. Results were expressed as percent-
ages. Bone formation was estimated by recording the
number of osteoid lines in the total core length.
Immunohistochemistry Analysis. Decalcified and
paraffin-embedded sections were dewaxed, hydrated,
and heat treated in 1 mM ethylene-diamine-tetra-acetic
acid (EDTA) buffer for antigenic unmasking. Sections
were incubated for 30 minutes at room temperature with
the following: prediluted tartrate resistant acid phos-
phatase (TRAP) (clone 26E5) and cathepsin K (poly-
clonal) to identify osteoclasts; cycloxygenase (COX-2)
(clone SP21); CD68 (clone KP1) to identify monocytes/
macrophages; or vimentin (clone V9) to identify mesen-
chymal cells (as positive control). All antibodies were
purchased from Master Diagnóstica (Granada, Spain).
The immunohistochemical study was done with an auto-
matic immunostainer (Autostainer 480, LabVision,
Fremont, CA, USA) using the micropolymer-peroxidase-
based method (Ultravision Quanto; Thermo Fisher Sci-
entific, Kalamazoo, MI, USA), followed by development
with diaminobenzidine (Master Diagnóstica). A milli-
meter scale in the eyepiece of a BH2 microscope
(Olympus) with a ¥40 objective was used to count the
number of positive cells per square millimeter.
Statistical Analysis. After descriptive analysis, the
Kruskal-Wallis and Mann-Whitney U test were used to
evaluate the significance of differences, comparing clini-
cal, morphological, and morphometric values. p < .05
was considered significant. SPSS-Windows 15.0 (SPSS
Inc., Chicago, IL, USA) was used for the analyses.
RESULTS
The mean age of the patients was 46.29 1 8.10 years, in a
range between 35 and 63 years. Mean sinus elevation
augmentation vertical resorption was 0.30 1 0.14 mm,
with no statistically significant differences among the
three study groups (Table 1).
Histological and Histomorphometric Results
After 6 months, 3 years, and 7 years, ABB particles
remained detectable on trabecular bone in a slightly
lower proportion than in the original graft (Figure 1). A
normal woven and lamellar pattern of trabecular bone
had formed throughout the graft in all patients receiving
ABB plus ACB (1:1) grafts, and biopsies from the aug-
mentation area showed this trabecular bone in different
proportions. Image analysis revealed similar mean
values for vital bone, nonmineralized connective tissue,
and remnant ABB particles at all three measurement
time points (see Table 1).
In all histological samples, multinuclear cells were
attached to the surface of ABB particles and had the same
shape and size as osteoclasts adhering to bone tissue.
Most of these cells showed osteoclastic features, includ-
ing polarization, ruffled border, and TRAP and cathepsin
K activity (Figure 2). However, as detailed in Table 1, a
significant decrease over time was observed (Kruskal-
Wallis test) in the osteoclast count (TRAP positive,
p = .014; cathepsin K positive, p = .021) and number of
osteoid lines (p = .038), whereas osteocyte and osteoblast
counts remained similar at all measurement time points.
The presence of canals, resorptive trails, and vessels
within ABB particles was observed in 45% of biopsies
at 6 months and in 100% of those at 3 and 7 years
(p < .047, Kruskal-Wallis test). In the majority of cases
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TABLE 1 Comparison of Clinical, Morphometric, and Immunohistochemical Variables in Human Maxillary Sinus
Augmentation Biopsies among Different Time Points
Variables 6 Months (n = 10) 3 Years (n = 4) 7 Years (n = 3) p Values*
Age 47.2 1 17.4 45.7 1 11.8 44.0 1 7.2 .706
Graft resorption 0.34 1 0.19 0.25 1 0.10 0.29 1 0.12 .694
Bone (%) 36.77 1 23.64 32.45 1 10.07 39.170 1 11.58 .170
ABB (%) 21.64 1 19.60 20.25 1 10.44 11.58 1 21.81 .551
CT (%) 41.58 1 16.41 47.29 1 8.9 49.23 1 6.01 .164
Osteocytes/mm2 783.55 1 545.67 838.71 1 645.77 574.19 1 212.90 .191
Osteoblasts/mm2 152.11 1 115.39 346.77 1 315.09 80.64 1 58.15 .226
Osteoclasts/mm2 215.26 1 70.13 99.19 1 44.23 40.10 1 29.70 .050
Osteoid lines 13.7 1 8.1 7.25 1 5.83 3.0 1 1.0 .038
CD68/mm2 28.69 1 25.68 65.42 1 34.32 31.18 1 27.05 .167
TRAP/mm2 242.17 1 66.18 42.22 1 30.26 34.15 1 42.90 .014
Cathepsin K/mm2 200.75 1 42.09 35.36 1 28.15 24.21 1 19.45 .021
Values are expressed as mean 1 standard deviation.
*Kruskal-Wallis test.
p Values with statistical significance are in bold.
ABB = anorganic bovine bone; CT = connective tissue; TRAP = tartrate resistant acid phosphatase.
A
B C
Figure 1 (A) Panoramic image of bone core biopsy taken after 7 years from maxillary sinus augmentation. Note the persistence of
anorganic bovine bone (ABB) particles (Masson trichrome, original magnification ¥2). Presence of canals, resorptive trails, and
vessels within ABB particles at 3 years (B) and 7 years (C) (asterisk) (Masson trichrome, original magnification ¥20).
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with the presence of Haversian and Volkmann’s canals,
ABB particles were recolonized by vessels through pre-
existing canals (see Figure 1).
DISCUSSION
The biodegradation of ABB is controversial. Some
authors found that ABB was resorbed in the host tis-
sue,26,27 but others reported that it was not.28,29 This dis-
crepancy may be attributable to differences in the type
of study (animal vs human studies), surgical approach,
biopsy technique, or histological evaluation method.18
In our samples, the significant decrease in osteoclast
count suggests a true reduction in biodegradation.
Wallace and colleagues followed the sequential
healing process of a sinus graft in a patient and detected
no signs of deproteinized bovine bone particles at 20
months of healing,30 but it is not clear whether this
finding reflected the biopsy technique used or was
truly the result of resorption. Other authors31 reported a
higher final amount of vital bone with greater amounts
of ABB in the graft (37.7 1 31.3% with 100% ACB vs
39.9 1 8% with 20% ACB: 80% ABB vs 41.7 1 26.6%
with 100% ABB), and similar results were obtained by
our group.25 This may imply greater resorption with the
placement of more ABB because 41.7% of the space
initially occupied by 100% ABB becomes new vital host
bone. However, although the initial amounts of each
biomaterial are known, it is not possible to evaluate
resorption by this mechanism because its precise distri-
bution within the defect is not known. One author
claimed that, because the structure of Bio-Oss®
(Geistlich Söhne AG, Wolhusen, Switzerland) is porous,
A B
C D
Figure 2 Osteoclast cell tartrate resistant acid phosphatase positive (asterisk) in maxillary sinus augmentation biopsies at 6 months
(A) and at 7 years (B) attached to the surface of anorganic bovine bone particles. Osteoclast cell cathepsin K positive (asterisk) at
6 months (C) and at 7 years (D). Note the significant decrease in the osteoclast count (polymer-peroxidase-based method, original
magnification ¥20).
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ABB could only occupy 25 to 30% of the available
space.17 For ethical reasons, biopsies are generally taken
from humans by using a trephine drill, which means that
the clinician has no precise knowledge of the original
position of the biopsy (direction, inclination, depth, and
buccopalatal distances) or the initial proportion of the
biomaterial in the selected area.
The measurement of surface ABB particles may not
be the most appropriate procedure to determine resorp-
tion. ABB (Bio-Oss) is obtained from two different bone
types, cortical and cancellous bone, which have different
resorption rates, and it is commercially available in two
particle sizes (0.25–1 and 1–2 mm).9 The variability of
particle size within the same sample is very high, and
differences in resorption cannot be established if the
initial pregraft size of particles is not known. Errors can
also be introduced through histological procedures such
as the decalcification of deproteinized bovine bone par-
ticles, which produces shrinkage that might be misinter-
preted as resorption.18
The presence of cortical autogenous bone is an
essential characteristic of our composite graft. Cobb and
colleagues compared the use of nonresorbable and low-
grade resorption bone substitutes and concluded that a
mixture of equal volumes of nonresorbable and autog-
enous bone was optimal for grafting.32 For the clinical
augmentation of a severely resorbed posterior maxilla, a
mixture of 50% ABB and 50% autogenous bone was
found to ensure the primary stability of dental implants
after a 6-month healing period.9 The advantage of
autogenous bone as a graft material is the rapid angio-
genic growth of vessels from the surrounding host bone.
This may help to vascularize parts of the graft and its
cells, which would subsequently participate in local
metabolism, leading to osteoclastic resorption and func-
tionally oriented osteoblastic remodeling. Resorption of
the autogenous bone includes the release of growth
factors involved in the formation of new capillary
sprouts (e.g., platelet-derived growth factor and trans-
forming growth factor beta), the proliferation of stem
cells, and the activation of macrophages.33 Grafted
autogenous bone particles appear to act as local bone
growth centers throughout the graft area34 and to
provide osteoclasts and their progenitors, which may
influence the remodeling of the total mineralized mass.9
However, the osteoclasts detected in our histological
preparations are unlikely to have derived from the origi-
nal autologous graft because these cores were obtained
after at least 6 months of healing, and Tadjoedin and
colleagues found that all original graft bone was remod-
eled after 5 months.9
If resorption occurs, it is important to establish the
types of cell that promote this event and surround the
ABB particles. Studies of biopsies harvested in humans
after 3 years found ABB particles to be in close contact
with giant cells but without exhibiting signs of resorp-
tion.27 Hallman and Thor interpreted lacunae on the
surfaces of deproteinized bovine bone particles as
lacunae present in the original donor material rather
than signs of possible resorption. They argued that
deproteinized bovine bone may be a nonresorbable
grafting material in humans18 and, even though giant
cells may be in the vicinity of ABB particles, osteoclastic
cells are unlikely to resorb or degrade bovine bone that
has been deproteinized. However, Tadjoedin and col-
leagues described the presence of numerous TRAP-
positive multinucleated cells in contact with ABB
granules, often localized in shallow resorption lacunae,
similarly what happens in some of our samples, suggest-
ing that ABB granules were gradually degraded and
resorbed by the activity of osteoclasts.9 This is a frequent
finding in our samples, in which TRAP-positive multi-
nucleated cells were consistently found both on the ABB
particles and within them (e.g., on canals), promoting
their central resorbability (see Figure 2). Furthermore,
our group previously demonstrated a considerably
higher amount of osteoclasts in the grafted area than in
the pristine maxillary bone.35
Numerous researchers have reported multinucle-
ated cells on the surface of ABB material,16,36,37 but it
remains to be elucidated whether they are active osteo-
clasts,16 nonactive/impaired osteoclasts,38 giant cells,15,27
or macrophages/monocytes undergoing fusion.22 The
clinical response may be influenced by the type of cells
presented, which is therefore a highly relevant issue.
Thus, giant cells differentiate in chronic inflammatory
sites in response to bacterial invasion and foreign bod-
ies,19 whereas the presence of osteoclasts may represent
normal bone tissue remodeling.
Some animal studies reported on the early phases of
healing, which are associated with inflammatory pro-
cesses20 that can alter normal hard tissue deposition,
and multinucleated cells found on the xenograft surface
during these phases may be giant cells. Araújo and col-
leagues proposed that neutrophilic leukocytes (poly-
morphonuclear cells) migrate to the surface of foreign
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particles during the first phase of healing and are
replaced with multinuclear TRAP-positive cells (osteo-
clasts) during a second phase. These osteoclasts remove
material from the xenogeneic graft surface but disappear
from the ABB granules after 1 to 2 weeks, when they are
followed by osteoblasts that lay down bone mineral in
the collagen bundles of the provisional matrix.16 This
phenomenon may explain the significant positive rela-
tionship in our samples between COX-2 expression in
multinucleated cells and greater bone formation (rs:
0.729, p = .04, Spearman test). Osteoblastic bone forma-
tion is usually associated with osteoclastic bone resorp-
tion39 in the remodeling process.10 However, according
to Araújo and colleagues40 no multinucleated cells can
be expected on the ABB surface after 3 months because
they undergo apoptosis and disappear after completing
their function. This contrasts with our clinical findings
of different multinucleated cells (CD68 positive) and
osteoclasts (TRAP and cathepsin K positive) after 6
months of healing, with no case of inflammatory
response being observed in our samples. It is reasonable
to assume that different cellular events are taking place
at 6 months and that different stages of differentiation of
these resorptive cells may coexist. Given that bone tissue
is under continuous remodeling, osteoclasts must be
present in the samples at this time (6 months), but tissue
remodeling behavior may vary over time. In the experi-
mental study by Araújo and colleagues, multinucleated
cells on the graft surface were almost never found in
resorption bays in tissue samples from grafted sites,
whereas morphologically similar cells present on adja-
cent surfaces of host bone were almost consistently
located in characteristic Howship’s lacunae and were
classified as active osteoclasts.15 The biological behavior
was different in our samples; after 6 months of healing,
osteoclasts were usually active on ABB particles, pro-
moting bone remodeling units, but they were rarely
active on new vital bone.
Osteoclast attachment and resorptive activity
involves the formation of cellular attachments to pro-
teins in the normal bone matrix41 or to proteins
adsorbed on the biomaterial surface.12 The present bio-
material is anorganic and therefore expected to contain
no proteins,18 compromising the biological effects of
osteoclasts,38 but some proteins were detectable on the
ABB particles in our samples. The distribution of
TRAP in our samples was of particular interest, being
expressed solely on the graft particles and never on vital
bone, indicating a selective resorption of the xenogeneic
material (see Figure 2). An identical expression pattern
was found for osteopontin (data not shown), which not
only activates osteoclasts for bone matrix resorption42
but can also induce osteoclast migration in an avb3
integrin-dependent manner.43 In support of this propo-
sition, osteoclast migration was found to be mediated
by phosphorylated osteopontin and regulated by the
endogenous TRAP.44
The significant decrease in the osteoclast count over
time in our series could suggest that the main cause of
ABB persistence is a reduction in remodeling activity.
CONCLUSION
Resorption of ABB material was observed in bone cores
from humans, with evidences of diverse active multi-
nucleated cells on this biomaterial. The present finding
of a decrease in osteoclast count over time would explain
the long-term persistence of ABB observed. Further
studies with more cases and different graft maturation
times are required to elucidate the resorption rates and
cell events underlying these phenomena.
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